| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $48.6M | +107.9% |
| Cost of Revenue | $25.9M | +197.3% |
| Gross Profit | $22.8M | +55.0% |
| R&D Expense | $7.8M | +34.9% |
| SG&A Expense | $13.8M | +34.8% |
| Operating Income | -$16.1M | +1.9% |
| Pre-tax Income | -$16.5M | -1.4% |
| Income Tax | $67K | +0.0% |
| Net Income | -$16.5M | -1.0% |
| EPS (Basic) | -$0.02 | +95.8% |
| EPS (Diluted) | -$0.02 | +95.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.8M | -14.3% |
| Short-term Investments | $2K | +0.0% |
| Accounts Receivable | $2.8M | +1370.8% |
| Current Assets | $14.7M | +8.5% |
| Total Assets | $52.5M | -2.1% |
| Current Liabilities | $10.1M | +22.9% |
| Total Liabilities | $10.1M | +22.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.3M | +51.0% |
| Capital Expenditures | $22K | -6.1% |
| Investing Cash Flow | $203K | -48.5% |
| Financing Cash Flow | $2.3M | -59.2% |
| Free Cash Flow | -$4.3M | +50.9% |
| Stockholders' Equity |
| $42.3M |
| -6.6% |